Jiangsu Hengrui Pharmaceuticals Co.,Ltd (SHA:600276)
China · Delayed Price · Currency is CNY 46.38
+0.44 (0.96%)
Jun 9, 2026, 3:00 PM CST
SHA:600276 Stock Forecast
Stock Price Forecast
According to 20 analysts polled by S&P Global, SHA:600276 stock has a consensus rating of "Strong Buy" and an average price target of ¥81.26. The average 1-year stock price forecast is 75.20% higher than the current stock price, while the lowest is ¥70.00 (+50.93%) and the highest is ¥123.00 (+165.20%).
Price Target: ¥81.26 (+75.20%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for SHA:600276 stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 16 | 16 | 17 | 16 | 16 | 15 |
| Buy | 5 | 5 | 4 | 4 | 4 | 4 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 1 | 1 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 23 | 23 | 22 | 21 | 21 | 20 |
Financial Forecast
Revenue This Year
36.01B
from 31.63B
Increased by 13.84%
Revenue Next Year
41.63B
from 36.01B
Increased by 15.61%
EPS This Year
1.48
from 1.14
Increased by 30.23%
EPS Next Year
1.73
from 1.48
Increased by 16.27%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 37.1B | ||
| Avg | 36.0B | ||
| Low | 34.1B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 17.2% | ||
| Avg | 13.8% | ||
| Low | 7.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 1.48 | ||
| Low | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 30.2% | ||
| Low | - |